Bio Vitos Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bio Vitos Pharma
Access all reports
Bio Vitos Pharma AB, previously known as Hemcheck Sweden AB, is a medical technology company based in Sweden. The company specializes in developing and commercializing solutions for the detection of hemolysis in blood samples. Their primary product is a combination of disposable tests and readers designed to quickly identify hemolyzed blood samples in vacuum tubes and blood gas syringes. This technology aims to enhance patient safety, streamline healthcare processes, and reduce costs by ensuring accurate blood sample analysis. Bio Vitos Pharma serves the healthcare sector, particularly targeting emergency departments in Europe and the United States. The company is headquartered in Solna, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
BIOVIT
Country
🇸🇪 Sweden